An ELISA can report a protein-associated concentration from an antibody-based signal. That number depends on what the antibodies recognise and how the sample compares with the calibration material. Read those relationships before interpreting a changed result as altered production of a particular molecule.
Identify how recognition produces the signal
Thermo Fisher’s technical guide describes antibody recognition in ELISA. Its separate Arg8-vasopressin competitive-assay documentation illustrates an inverse readout: more sample analyte corresponds to less colour signal. Signal direction must therefore be read from the actual format.Thermo Fisher — ELISA Technical Guide and Protocols (opens in a new tab)Thermo Fisher — Arg8-Vasopressin Competitive ELISA Kit, method principle (opens in a new tab)
Record the named analyte and any relevant molecular form. If the paper concerns a fragment, precursor or modified form, ask whether the assay documentation establishes recognition of that material and distinguishes it from related molecules.
A familiar protein name on the kit does not settle every specificity question. The useful evidence concerns the antibodies, calibration material and validation in the sample type being analysed.
In a peptide experiment, also distinguish the material added to the system from the molecule subsequently measured. A cytokine endpoint after peptide exposure is not a direct concentration measurement of the peptide.
Keep the sample within a justified measurement comparison
A concentration estimate comes from relating sample signal to a calibration response. Read the reported range and analysis method. A sample outside the usable range does not become quantified merely because the software extends a fitted curve.
Suppose an original fictional assay estimates 12 units per millilitre in a sample diluted fivefold before measurement. If the method and correction are valid, the corresponding original-sample estimate is 60 units per millilitre.
| Step | Value |
|---|---|
| Measured diluted sample | 12 units/mL |
| Dilution factor | 5 |
| Original-sample estimate | 12 × 5 = 60 units/mL |
Check whether the paper has already applied that correction. Multiplying a corrected result again would overstate the concentration. Keep the sample stage beside the number instead of relying on an ambiguous concentration heading.
Ask whether standards and samples behave comparably
Thermo Fisher’s spike-and-recovery guidance explains that sample components can alter the response relative to standard diluent. It distinguishes recovery of added analyte from dilutional linearity, which examines whether measured results behave predictably across known dilutions.Thermo Fisher — Spike-and-recovery and linearity-of-dilution experiments (opens in a new tab)
These checks address whether the biological sample can be interpreted through the calibration. A good-looking standard curve alone describes the standards; it does not establish that every sample behaves the same way.
For an original fictional comparison, two dilutions give inconsistent estimates after correction back to the original sample. That disagreement raises a measurement question. It should be investigated rather than resolved by selecting whichever estimate better supports the proposed effect.
The appropriate interpretation depends on the assay’s evidence and acceptance criteria. Do not impose a universal recovery percentage from another kit or assume that dilution removes every possible interference.
Separate concentration from the process producing it
A peptide-associated difference in a measured culture-medium concentration is an endpoint observation. It does not, on its own, distinguish altered release, a different number of contributing cells or another change affecting the amount present at sampling.
Read the sampling interval and population information if the authors describe a secretion or production rate. A rate requires a time basis and an argument connecting the measured amount to the process of interest.
Likewise, immunoreactivity does not automatically establish biological activity. If the paper makes that claim, follow the functional measurement or other evidence supporting it.
A useful summary states the recognised analyte, sample type, calibrated comparison and relevant corrections. It should identify any unresolved specificity or sample-matrix issue and keep the observed concentration separate from the proposed biological explanation.
Sources and further detail
- Thermo Fisher — ELISA Technical Guide and Protocols (opens in a new tab)
Technical guide read for antibody recognition and sample/standard considerations. Brief conceptual summary only; no operational protocol reproduced.
- Thermo Fisher — Spike-and-recovery and linearity-of-dilution experiments (opens in a new tab)
Official Tech Tip 58 principle sections read for matrix response, recovery and dilutional linearity. No universal acceptance limit adopted. Dilution and discordance examples are original.
- Thermo Fisher — Arg8-Vasopressin Competitive ELISA Kit, method principle (opens in a new tab)
Official indexed method principle read solely for the inverse competitive signal. No operating conditions or product-validation guarantee adopted.
Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.